CWA
ABBV icon

CJM Wealth Advisers’s AbbVie ABBV Stock Holding History

CJM Wealth Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+930
New +$200K 0.06% 71
2026
Q1 		– Sell
-943
Closed -$216K – 73
2025
Q4 		$216K Buy
943
+11
+1% +$2.51K 0.06% 71
2025
Q3 		$216K Buy
+932
New +$190K 0.07% 70

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

CJM Wealth Advisers's ABBV Position: Q2 2026 in Review

CJM Wealth Advisers opened a new position in AbbVie (ABBV) in Q2 2026: 930 shares worth $234K. The stake represents 0.06% of the portfolio and ranks #71 among its holdings. This is a return to the name: CJM Wealth Advisers previously reported a position in ABBV as recently as Q4 2025.

CJM Wealth Advisers first reported a position in ABBV in Q3 2025 and has held it in 3 quarters since. 1,043 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • CJM Wealth Advisers held 930 shares of AbbVie worth $234K as of Q2 2026.
  • AbbVie was a new CJM Wealth Advisers position in Q2 2026.
  • AbbVie made up 0.06% of CJM Wealth Advisers's portfolio in Q2 2026, its #71 holding.
  • CJM Wealth Advisers first reported a position in AbbVie in Q3 2025 and has held it in 3 quarters since.
  • 1,043 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on CJM Wealth Advisers's 13F filing for Q2 2026, filed 17 Jul 2026.